Press release
Global Sartans Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Sartans Market Growth
How Big Is the Sartans Market Size Expected to Be by 2034?
The sartans market has experienced a consistent growth over the recent years. It is forecasted to expand from $21.36 billion in 2024 to $22.39 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.8%. The notable growth in the historical period can be credited to the rise in sedentary lifestyles, growing obesity rates, heightened awareness of cardiovascular diseases, increased healthcare spending, and the surging demand for generic antihypertensive medications.
In the coming years, the market size of sartans is predicted to experience consistent expansion, ballooning to $26.66 billion by 2029 with a compound annual growth rate (CAGR) of 4.5%. This growth during the projected period is attributable to the escalating attention on combination treatments, increased funding in pharmaceutical research and development, surge in demand from emerging markets, growth of healthcare infrastructure, and a higher incidence of lifestyle-related illnesses. The forecast period is also expected to see significant trends such as improvements in drug delivery technologies, enhanced production processes for Active Pharmaceutical Ingredients (APIs), the inception of fixed-dose combination medications, innovation in custom hypertension treatment, and the creation of new sartan derivatives.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp
What Are the Emerging Segments Within the Sartans Market?
The sartans market covered in this report is segmented -
1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp
What Long-Term Drivers Are Shaping Sartans Market Trends?
The upward trend in hypertensive conditions is set to stimulate expansion in the sartans market. Identified by continuous high blood pressure, hypertension heightens the risk of heart disease, stroke, and other serious health issues. The escalating number of hypertension cases corresponds with salt and processed food-heavy diets, which result in fluid accumulation and amplified stress on the heart. Sartans mitigate hypertension by preventing angiotensin II, a hormone that constricts blood vessels. This serves to relax and widen these vessels, thereby reducing blood pressure and minimizing strain on the heart. In January 2024, the American Heart Association, a nonprofit organization based in the US, reported that there were 131,454 deaths primarily due to high blood pressure in 2022, marking a rise from 124,508 deaths in 2021. Consequently, the increased frequency of hypertension cases is fueling the progress of the sartans market.
Who Are the Top Competitors in Key Sartans Market Segments?
Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.
What Are the Major Trends Shaping the Sartans Market?
Leading enterprises in the sartans market are strategizing their growth by innovating and enhancing products, particularly sartans in tablet form, to improve patient compliance and therapeutic effectiveness. Sartan tablets are orally administered medications that contain sartan drugs designed to obstruct angiotensin II's impacts, inducing blood vessel relaxation and diminishing blood pressure. For instance, in July 2024, the US FDA approved Valsartan Tablets USP (40 mg, 80 mg) manufactured by the Indian pharmaceutical firm, Zydus Lifesciences. Sold under the trademark name Diovan, these tablets are employed to manage heart failure and hypertension, increase survival chances after a heart attack in adults, and are also appropriate for children aged over one year.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/sartans-global-market-report
Which Regions Are Becoming Hubs for Sartans Market Innovation?
North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Sartans Market?
2. What is the CAGR expected in the Sartans Market?
3. What Are the Key Innovations Transforming the Sartans Industry?
4. Which Region Is Leading the Sartans Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Sartans Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities here
News-ID: 4060662 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
